We are very pleased to have been guests at the joint 2026 annual reception of the University Medical Centers of Rostock and Greifswald. In the refectory of the University of Greifswald, representatives from politics, academia, industry and civil society came together to discuss one central question: how do we secure health care, innovation and societal resilience in times of profound change?
The focus was on the role of university medicine as part of modern public services, from prevention through cutting-edge medicine to an aspect that is particularly close to our hearts as a young company: the transfer of scientific findings into economic and societal application.
That is exactly what Ymolution stands for. As a spin-off from University Medicine Greifswald, we are a living example of how excellent basic research gives rise to a regional company with international ambitions. Our Managing Director Dr. Alexander Reder represented Ymolution that evening and contributed to the discussion, in excellent company that included Minister President Manuela Schwesig, Dr. Christoph Hüls of Max Planck Innovation and Stefan Miltenyi of Miltenyi Biotec.
For us, the evening once again underlined how important close dialogue between academia, politics and industry is in order to translate research into real impact. We thank the University Medical Centers of Rostock and Greifswald for the invitation and the inspiring input, and we are taking away plenty of motivation to further advance our fully synthetic, animal-free nano-antibodies “made in Greifswald”.
You can find more about the event at the University Medical Centers of MV.
Would you like to learn more about our technology or work with us? Get in touch.
The Ymolution team









